Completed OBSERVATIONAL NCT01285726

Initiative for Patient Outcomes in Dialysis - Peritoneal Dialysis (PD) (IPOD-PD Study) (IPOD-PD)

Initiative for Patient Outcomes in Dialysis - PD (IPOD-PD Study)

Sponsor: Fresenius Medical Care Deutschland GmbH

Updated 7 times since 2017 Last updated: Apr 29, 2016 Started: Jan 31, 2011 Primary completion: Dec 31, 2015 Completion: Dec 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Chronic Renal Failure, this trial is completed. The trial is conducted by Fresenius Medical Care Deutschland GmbH and has accumulated 7 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2025 — Present [monthly]

Completed
Sep 2024 — Sep 2025 [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed

▶ Show 2 earlier versions

Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None
Jan 2017 — Apr 2018 [monthly]

Completed NA

First recorded

Jan 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Fresenius Medical Care Deutschland GmbH

Data source: Fresenius Medical Care Deutschland GmbH

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

A Coruña, Spain , Aalst, Belgium , Albacete, Spain , Alcorcón, Spain , Alexandroupoli, Greece , Almería, Spain , Antalya, Turkey (Türkiye) , Athens, Greece , Barcelona, Spain , Bari, Italy and 108 more locations